Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Habano, Wataru ^a   Gamo, Toshie ^a   Terashima, Jun ^a   Sugai, Tamotsu ^a   Otsuka, Koki ^a   Wakabayashi, Go ^a   Ozawa, Shogo ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A4; MESSENGER RNA; PREGNANE X RECEPTOR; VITAMIN D RECEPTOR; 5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; CALCITRIOL RECEPTOR; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450 3A; DRUG DERIVATIVE; STEROID RECEPTOR;

ARTICLE; CANCER CELL; CARCINOGENESIS; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PROMOTER REGION; UPREGULATION; CARCINOMA; CELL STRAIN CACO 2; CELL STRAIN HCT116; CELL STRAIN HT29; COLON TUMOR; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

AZACITIDINE; CACO-2 CELLS; CARCINOMA; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYTOCHROME P-450 CYP3A; DNA METHYLATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HT29 CELLS; HUMANS; PROMOTER REGIONS, GENETIC; RECEPTORS, CALCITRIOL; RECEPTORS, STEROID;

EID: 79951777299     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-81     Document Type: Article

References (28)

1. Zhang B, Xie W, Krasowski MD. PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics. Pharmacogenomics 2008, 9:1695-1709. 10.2217/14622416.9.11.1695, 2593625, 19018724.
2. Zhou C, Verma S, Blumberg B. The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism. Nucl Recept Signal 2009, 7:e001. 2646121, 19240808.
3. Kliewer SA, Goodwin B, Willson TM. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev 2002, 23:687-702. 10.1210/er.2001-0038, 12372848.
4. Lamba JK, Lin YS, Schuetz EG, Thummel KE. Genetic contribution to variable human CYP3A-mediated metabolism. Adv Drug Deliv Rev 2002, 54:1271-1294. 10.1016/S0169-409X(02)00066-2, 12406645.
5. von Richter O, Burk O, Fromm MF, Thon KP, Eichelbaum M, Kivistö KT. Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens. Clin Pharmacol Ther 2004, 75:172-183. 10.1016/j.clpt.2003.10.008, 15001968.
6. Zhang QY, Dunbar D, Ostrowska A, Zeisloft S, Yang J, Kaminsky LS. Characterization of human small intestinal cytochromes P-450. Drug Metab Dispos 1999, 27:804-809.
7. Turan N, Katari S, Coutifaris C, Sapienza C. Explaining inter-individual variability in phenotype: Is epigenetics up to the challenge?. Epigenetics 2010, 5:16-19. 10.4161/epi.5.1.10557, 2829373, 20083905.
8. Demura M, Bulun SE. CpG dinucleotide methylation of the CYP19 I.3/II promoter modulates cAMP-stimulated aromatase activityMol Cell. Endocrinol 2008, 283:127-132.
9. Misawa A, Inoue J, Sugino Y, Hosoi H, Sugimoto T, Hosoda F, Ohki M, Imoto I, Inazawa J. Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification. Cancer Res 2005, 65:10233-10242. 10.1158/0008-5472.CAN-05-1073, 16288011.
10. Habano W, Gamo T, Sugai T, Otsuka K, Wakabayashi G, Ozawa S. CYP1B1, but not CYP1A1, is downregulated by promoter methylation in colorectal cancers. Int J Oncol 2009, 34:1085-1091. 10.3892/ijo_00000235, 19287966.
11. Habano W, Sugai T, Nakamura S, Yoshida T. A novel method for gene analysis of colorectal carcinomas using a crypt isolation technique. Lab Invest 1996, 74:933-940.
12. CpG Island Searcher. , http://cpgislands.usc.edu/
13. Takai D, Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 2002, 99:3740-1833745. 10.1073/pnas.052410099, 122594, 11891299.
14. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987, 196:261-282. 10.1016/0022-2836(87)90689-9, 3656447.
15. Xiong Z, Laird PW. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997, 25:2532-2534. 10.1093/nar/25.12.2532, 146738, 9171110.
16. Hartley DP, Dai X, Yabut J, Chu X, Cheng O, Zhang T, He YD, Roberts C, Ulrich R, Evers R, Evans DC. Identification of potential pharmacological and toxicological targets differentiating structural analogs by a combination of transcriptional profiling and promoter analysis in LS-180 and Caco-2 adenocarcinoma cell lines. Pharmacogenet Genomics 2006, 16:579-599. 10.1097/01.fpc.0000220561.59972.7a, 16847427.
17. Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, Ishizuka H, Kharasch E, Schuetz J, Schuetz E. Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3. Mol Pharmacol 2001, 60:1399-1406.
18. Aouabdi S, Gibson G, Plant N. Transcriptional regulation of the PXR gene: identification and characterization of a functional peroxisome proliferator-activated receptor alpha binding site within the proximal promoter of PXR. Drug Metab Dispos 2006, 34:138-144. 10.1124/dmd.105.006064, 16243957.
19. Kurose K, Ikeda S, Koyano S, Tohkin M, Hasegawa R, Sawada J. Identification of regulatory sites in the human PXR (NR1I2) promoter region. Mol Cell Biochem 2006, 281:35-43. 10.1007/s11010-006-0167-7, 16328955.
20. Kurose K, Koyano S, Ikeda S, Tohkin M, Hasegawa R, Sawada J. 5' diversity of human hepatic PXR (NR1I2) transcripts and identification of the major transcription initiation site. Mol Cell Biochem 2005, 273:79-85. 10.1007/s11010-005-7757-7, 16013442.
21. Carlberg C, Bendik I, Wyss A, Meier E, Sturzenbecker LJ, Grippo JF, Hunziker W. Two nuclear signalling pathways for vitamin D. Nature 1993, 361:657-660. 10.1038/361657a0, 8382345.
22. Xie Y, Ke S, Ouyang N, He J, Xie W, Bedford MT, Tian Y. Epigenetic regulation of transcriptional activity of pregnane X receptor by protein arginine methyltransferase 1. J Biol Chem 2009, 284:9199-9205. 10.1074/jbc.M806193200, 2666572, 19144646.
23. Kojima K, Nagata K, Matsubara T, Yamazoe Y. Broad but distinct role of pregnane X receptor on the expression of individual cytochrome P450 in human hepatocytes. Drug Metab Pharmacokinet 2007, 22:276-286. 10.2133/dmpk.22.276, 17827782.
24. Raynal C, Pascussi JM, Leguelinel G, Breuker C, Kantar J, Lallemant B, Poujol S, Bonnans C, Joubert D, Hollande F, Lumbroso S, Brouillet JP, Evrard A. Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation. Mol Cancer 2010, 9:46. 10.1186/1476-4598-9-46, 2838814, 20196838.
25. Ouyang N, Ke S, Eagleton N, Xie Y, Chen G, Laffins B, Yao H, Zhou B, Tian Y. Pregnane X receptor suppresses proliferation and tumourigenicity of colon cancer cells. Br J Cancer 2010, 102:1753-1761. 10.1038/sj.bjc.6605677, 20531417.
26. Zhou J, Liu M, Zhai Y, Xie W. The antiapoptotic role of pregnane X receptor in human colon cancer cells. Mol Endocrinol 2008, 22:868-880. 10.1210/me.2007-0197, 2276464, 18096695.
27. Wheeler JM, Beck NE, Kim HC, Tomlinson IP, Mortensen NJ, Bodmer WF. Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: The predominant role of hMLH1. Proc Natl Acad Sci USA 1999, 96:10296-10301. 10.1073/pnas.96.18.10296, 17882, 10468602.
28. Lind GE, Thorstensen L, Lovig T, Meling GI, Hamelin R, Rognum TO, Esteller M, Lothe RA. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer 2004, 3:28. 10.1186/1476-4598-3-28, 526388, 15476557.